OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond
Wanxu Huang, Hua Li, Qingsong Yu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Yanlin Wu, Zhengjun Lin, Changchun Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 185

LINC02282 promotes DNA methylation of TRIM6 by recruiting DNMTs to inhibit the progression of Parkinson's disease
Lu Han, Chuansheng Zhao, Jin Feng, et al.
Brain Research Bulletin (2025), pp. 111224-111224
Open Access | Times Cited: 2

The epigenetic regulatory mechanism of PIWI/piRNAs in human cancers
Qun Zhang, Yazhi Zhu, Xinyu Cao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 40

Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer
Xiu-Rui Hsu, Jiaen Wu, Yi-Ying Wu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 28

Roles of lncRNAs in NF-κB-Mediated Macrophage Inflammation and Their Implications in the Pathogenesis of Human Diseases
Jae-Joon Shin, Jeongkwang Park, Hyeung‐Seob Shin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2670-2670
Open Access | Times Cited: 10

New mechanism of LncRNA: In addition to act as a ceRNA
Jiahao Zhang, Huike Zhu, Linjing Li, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1050-1060
Open Access | Times Cited: 9

Prognostic value of long non-coding RNA MALAT1 in hepatocellular carcinoma: A study based on multi-omics analysis and RT-PCR validation
Xiaoli Liao, Junming Chen, DongCheng Luo, et al.
Pathology & Oncology Research (2023) Vol. 28
Open Access | Times Cited: 19

Long Non-Coding RNAs in Colorectal Cancer: Navigating the Intersections of Immunity, Intercellular Communication, and Therapeutic Potential
Nikolay K. Shakhpazyan, Л.М. Михалева, A.L. Bedzhanyan, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2411-2411
Open Access | Times Cited: 19

Insights into DNMT1 and programmed cell death in diseases
Lan Yan, Qi Geng, Zhiwen Cao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115753-115753
Open Access | Times Cited: 18

Advances and challenges of first-line immunotherapy for non-small cell lung cancer: A review
Haiyang Guo, Jun Zhang, Chao Qin, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36861-e36861
Open Access | Times Cited: 7

From molecular pathogenesis to therapy: Unraveling non-coding RNAs/DNMT3A axis in human cancers
Chunjie Huang, Seyed Mohsen Aghaei Zarch
Biochemical Pharmacology (2024) Vol. 222, pp. 116107-116107
Closed Access | Times Cited: 7

Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy
Ting Chen, Syrine Mahdadi, Michel Vidal, et al.
Pharmacological Research (2024) Vol. 207, pp. 107328-107328
Open Access | Times Cited: 7

RNA epigenetics in pulmonary diseases: Insights into methylation modification of lncRNAs in lung cancer
Junjie Jiang, Minghao Duan, Zheng Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116704-116704
Open Access | Times Cited: 6

The interactions between DNA methylation machinery and long non-coding RNAs in tumor progression and drug resistance
Mokhtar Jawad Al-Imam, Uday Abdul‐Reda Hussein, Fadhil Faez Sead, et al.
DNA repair (2023) Vol. 128, pp. 103526-103526
Closed Access | Times Cited: 15

Long non-coding RNA-targeting therapeutics: discovery and development update
Olga Khorkova, Jack Stahl, Aswathy Joji, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 9, pp. 1011-1029
Closed Access | Times Cited: 15

The Effect of Race/Ethnicity and MED12 Mutation on the Expression of Long Non-Coding RNAs in Uterine Leiomyoma and Myometrium
Tsai‐Der Chuang, Nhu Ton, Shawn Rysling, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1307-1307
Open Access | Times Cited: 5

The role of long non-coding RNA ANRIL in the development of atherosclerosis
Ilgiz Gareev, Valentin Kudriashov, Albert Sufianov, et al.
Non-coding RNA Research (2022) Vol. 7, Iss. 4, pp. 212-216
Open Access | Times Cited: 22

Noncoding RNA as an influential epigenetic modulator with promising roles in cancer therapeutics
Laboni Roy, Oishika Chatterjee, Debopriya Bose, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103690-103690
Closed Access | Times Cited: 12

H1Innovative approaches to combat anti‐cancer drug resistance: Targeting lncRNA and autophagy
Chenming Zhong, Zijun Xie, Shiwei Duan
Clinical and Translational Medicine (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 11

LncRNAs Affecting NF-κB-Mediated Macrophage Inflammation Are Potential Therapeutic Targets in Human Diseases
Jae-Joon Shin, Jeong-kwang Park, Hyeung‐Seob Shin, et al.
(2024)
Open Access | Times Cited: 4

LncRNA CTBP1‐AS inhibits TP63‐mediated activation of S100A14 during prostate cancer progression
Guangzheng Wu, Zhenkun Dong, Yuhang Dong, et al.
Cancer Science (2024) Vol. 115, Iss. 5, pp. 1492-1504
Open Access | Times Cited: 4

LncRNAs and the Cancer Epigenome: Mechanisms and Therapeutic Potential
Revathy Nadhan, Ciro Isidoro, Yong Sang Song, et al.
Cancer Letters (2024) Vol. 605, pp. 217297-217297
Closed Access | Times Cited: 4

Adaptive Significance of Non-coding RNAs: Insights from Cancer Biology
John F. McDonald
Molecular Biology and Evolution (2025) Vol. 42, Iss. 1
Open Access

Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma
Nikita Mehra, Suchitra Sundaram, Parth Shah, et al.
Current Oncology Reports (2025)
Closed Access

LncRNA MIR17HG drives cisplatin resistance partially via miR-138-5p/AKAP9 axis in cholangiocarcinoma
Ling‐Yu Tang, Yuting Wang, Yongzhen Chen, et al.
Scandinavian Journal of Gastroenterology (2025), pp. 1-13
Closed Access

Page 1 - Next Page

Scroll to top